Cannabis Report
Home > Boards > US Listed > Biotechs >

Enanta Pharmaceuticals (ENTA)

ENTA RSS Feed
Add ENTA Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board: 
Last Post: 5/18/2018 10:28:28 AM - Followers: 64 - Board type: Free - Posts Today: 0
Cannabis Report
ENTA
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ENTA News: Statement of Changes in Beneficial Ownership (4) 05/18/2018 06:03:51 PM
ENTA News: Statement of Changes in Beneficial Ownership (4) 05/18/2018 05:55:04 PM
ENTA News: Statement of Ownership (sc 13g) 05/10/2018 05:32:58 PM
ENTA News: Quarterly Report (10-q) 05/10/2018 04:23:36 PM
ENTA News: Current Report Filing (8-k) 05/08/2018 04:09:34 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#1620  Sticky Note ABBV raises 2018 HCV sales guidance to $3.5B DewDiligence 04/26/18 09:12:23 AM
#1644   Mavyret's market share was essentially flat for the DewDiligence 05/18/18 10:28:27 AM
#1643   any news on scrip market share for last week? JK2016 05/18/18 10:13:27 AM
#1642   ABBV's Mavyret weekly NRx market share of the guyschmid 05/11/18 07:47:53 AM
#1641   ENTA’s EV ~$1.85B: #msg-140701639. DewDiligence 05/10/18 04:59:44 PM
#1640   The FY2Q18 10-Q has been filed: DewDiligence 05/10/18 04:27:13 PM
#1639   ENTA new corporate slide set: DewDiligence 05/10/18 03:42:51 PM
#1638   Transcript of ENTA FY2Q18 CC: DewDiligence 05/09/18 03:26:14 PM
#1637   I don't know what the Wall Street consensus DewDiligence 05/08/18 05:07:56 PM
#1636   This EPS better/worse than expected? Positive news? CricketPie09 05/08/18 05:01:55 PM
#1635   ENTA FY2Q18 results—$44M revenue—EPS=$0.61: DewDiligence 05/08/18 04:09:34 PM
#1634   Yes, here's to patience and 100.+ share price. willyw 05/05/18 09:47:31 AM
#1633   It's been a fun ride. Time for a 10nisman 05/04/18 04:17:32 PM
#1632   Yes, ENTA closes over $100! vinmantoo 05/04/18 04:09:24 PM
#1629   ABBV's Mavyret weekly NRx market share of the guyschmid 05/04/18 08:27:45 AM
#1628   Yes, I do. But one has to be DewDiligence 04/29/18 12:13:45 PM
#1627   Dew, can’t help asking..knowing what you know (execution, kris_kade 04/29/18 10:10:32 AM
#1626   It was never that low. My first buy DewDiligence 04/27/18 08:46:49 PM
#1625   Hey Dew, I remember when you were talking faxedreceipts 04/27/18 07:10:45 PM
#1624   Nice! (eom) DewDiligence 04/27/18 09:03:30 AM
#1623   ABBV's Mavyret weekly NRx market share of the guyschmid 04/27/18 08:57:57 AM
#1622   There are no additional Mavyret milestone payments. Please DewDiligence 04/26/18 12:12:35 PM
#1621   Thanks Dew. I was wondering why ENTA is vinmantoo 04/26/18 12:00:16 PM
#1620   ABBV raises 2018 HCV sales guidance to $3.5B DewDiligence 04/26/18 09:12:23 AM
#1619   ABBV reports $919M of 1Q18 HCV sales: #msg-140323816. DewDiligence 04/26/18 08:39:23 AM
#1618   ABBV's Mavyret weekly NRx market share of the guyschmid 04/20/18 10:09:48 AM
#1617   More details on Mavyret scripts for week ending DewDiligence 04/13/18 09:46:35 AM
#1616   HCV Weekly NRx Market Share for Week Ending guyschmid 04/13/18 07:24:45 AM
#1615   Latest corporate slide set (3/20/18): DewDiligence 04/12/18 09:49:06 AM
#1614   ENTA’s HBV and NASH presentations at EASL: DewDiligence 04/12/18 09:46:56 AM
#1613   HCV Weekly NRx Market Share for Week Ending guyschmid 04/06/18 08:24:20 AM
#1612   For Mavyret scripts in the week ending 3/23, DewDiligence 04/02/18 01:27:46 PM
#1611   any data on Nrx ending 3/31? JK2016 04/02/18 11:20:09 AM
#1610   ENTA’s EASL presentation lineup: DewDiligence 03/28/18 10:10:10 AM
#1609   Agreed (eom). DewDiligence 03/23/18 02:08:56 PM
#1608   The earlier pair of weeks prior had also willyw 03/23/18 01:27:00 PM
#1607   In other words, flat vs the prior week. DewDiligence 03/23/18 09:18:32 AM
#1606   HCV Weekly NRx Market Share for Week Ending guyschmid 03/23/18 08:48:43 AM
#1605   Today’s Wainwright webcast had no new info—it can DewDiligence 03/19/18 05:26:46 PM
#1604   Latest corporate slide set (2/16/18): DewDiligence 03/19/18 04:09:56 PM
#1603   Excellent news! Additional details at #msg-139340872. DewDiligence 03/16/18 10:36:10 AM
#1601   ABBV's Mavyret weekly NRx market share of the guyschmid 03/16/18 08:59:10 AM
#1600   More on the same topic: #msg-139162802. DewDiligence 03/09/18 10:20:18 AM
#1599   ABBV's Mavyret weekly NRx market share of the guyschmid 03/09/18 08:20:52 AM
#1598   Mavyret’s market share grows in week ending 2/23/18: #msg-138970464. DewDiligence 03/02/18 10:18:09 AM
#1597   Brief comments on the differentiation of ENTA’s RSV DewDiligence 02/24/18 02:20:50 PM
#1596   Mavyret scripts plateaued in the week ending 2/16/18: #msg-138790811. DewDiligence 02/23/18 01:14:15 PM
#1595   ENTA's latest pipeline chart (from Leerink webcast): DewDiligence 02/18/18 01:42:16 PM
#1594   Mavyret scripts continue ramp-up: #msg-138602647. DewDiligence 02/16/18 08:52:29 AM
#1593   ENTA to present at Leerink & RBC conferences: DewDiligence 02/12/18 09:02:15 AM
#1592   ENTA's enterprise value: #msg-138447591. DewDiligence 02/10/18 06:49:57 PM
PostSubject